Locafy Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement

Locafy Limited (NASDAQ:LCFY, LCFYW)))) ("Locafy" or "the Company"), has received a deficiency notification letter ("Notice") from the Listing Qualifications Staff of the Nasdaq Stock Market

Locafy Limited (NASDAQ:LCFY, LCFYW))))) (“Locafy” or “the Company”), has received a deficiency notification letter (“Notice”) from the Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) because the bid price for the Company’s Ordinary Shares had closed below $1.00 per share for the previous 30 consecutive business days.

In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days from the date of such notice, or until December 27, 2022, to regain compliance with the minimum bid price requirement. To regain compliance, the bid price for the Company’s Ordinary Shares must close at $1.00 per share or more for a minimum of 10 consecutive business days.

Nasdaq’s written notice has no effect at this time on the listing or trading of the Company’s Ordinary Shares and the Ordinary Shares will continue to trade uninterrupted on Nasdaq under the symbol “LCFY”. The Company’s operations are not affected by the receipt of the Notice and Locafy’s management intends to actively monitor the bid price for its Ordinary Shares and will consider all available options to regain compliance with the Nasdaq minimum bid price requirement.

In the event Locafy does not regain compliance, the Company may be eligible for an additional 180 calendar days’ extension to regain compliance. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for the The Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice of its intention to resolve the deficiency during the second compliance period.

Total
0
Shares
Related Posts
Read More

Latin American Cannabis Co. Blueberries Medical Wraps Up 2023 With Multi-Million Dollar Private Placement Deal

Blueberries Medical, a Latin American licensed producer of medicinal cannabis and cannabis-derived products, has announced a non-brokered private placement, to raise approximately CA$1.9m ($1.4m). The company announced the sale of 180,716,00 common shares at CA$0.011 per share. The net proceeds from the sale will be used to repay existing debt and for general corporate and working capital purposes. The offering was led by Terraflos, a Latin American company founded and controlled by Facundo Garreton, who serves as Blueberries' chairman, CEO, and director. Terraflos is exploring opportunities in Argentina, Mexico, and Brazil and plans to expand into those markets in the near future.

ALID